Press Releases
- Leading immunologist recognised for breakthrough discovery that could transform patient care in severe respiratory viral infections
- TGA registration of Exdensur (depemokimab) offers a new treatment option for Australians living with severe asthma
- Older Australians recognise RSV can be serious, but many don't consider it a personal risk, new research suggests
